MASS · NASDAQ · Medical - Specialties

908 Devices (MASS)

Builds handheld instruments that identify hazardous chemicals at the point of need.

$10.39
Pre-market+0.05 (+0.48%)
At close$10.34(−2.91%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue14147111519121314171316
Cost of revenue6745710677978
Gross profit874689667968
171711153229172212121321
Research & development653447443334
00000000991011
General & administrative0000000000011
Other expenses1112811282313170006
Operating income−9−10−8−9−24−20−11−15−6−3−7−13
22211112−97−51
Interest income222111111110
Other non-operating income00−2−1−18−10−2−79−75−1
Income before tax−7−7−6−8−24−20−10−13−154−12−12
Income tax expense000000000000
Net income from continuing operations−7−7−6−8−24−19−10−13−154−12−12
Discontinued operations00−5−5−605300000
Net income−7−7−11−13−29−1944−13−154−12−12
EPS, basic−$0.22−$0.23−$0.33−$0.37−$0.68−$0.57$1.23−$0.37−$0.41$0.12−$0.32−$0.32
EPS, diluted−$0.22−$0.23−$0.33−$0.37−$0.68−$0.57$1.23−$0.37−$0.41$0.10−$0.32−$0.32
Weighted average shares, basic323233343535353636363738
Weighted average shares, diluted323233343535353636393738
EBITDA−8−10−5−7−5−9−7−7−145−11−11
Depreciation & amortization101111111111
EBIT−9−10−6−8−6−10−9−8−154−12−12